The last thing American taxpayers needed was psychiatry receiving additional government funding. Now, with the help of Obamacare, this network of mental incompetents have found a new boon to the tune of hundreds of millions of dollars. In section 4101 in the Patient Protection and Affordable Care Act (i.e. Obamacare), it provides for:
. . . grants for school-based health centers, which will offer, “comprehensive health assessments, diagnosis, and treatment of minor, acute, and chronic medical conditions” and “mental health and substance use disorder assessments, crisis intervention, counseling, treatment, and referral to a continuum of services including emergency psychiatric care, community support programs, inpatient care, and outpatient programs.”
According to the National Assembly on School-Based Health Care (NASBHC), “grants will allow the programs to increase the number of patients they serve to 1.2 million, a more than 50 percent jump from the current 790,000. Some of the grant money will be aimed specifically at improving mental health services.”
And these costs to finance psychiatry’s new found cash cow will be passed onto the American tax payer. By the year 2016, the Obamacare “penalty” tax will cost roughly $2,000 per year for a two-person household. According to Stephen Moore of the Wall Street Journal, 75% of the financial burden of Obamacare’s new taxes will fall onto Americans making less than $120,000 a year (http://www.humanevents.com/2012/06/30/wsj-chief-economist-75-of-obama…). The great Middle Class, in other words, will bear this new tax more than anyone else.
Obamacare & Big Pharma
Obama and Big Pharma did work together in 2009 in secret negotiations before the Affordable Care Act was to be law. In closed-door negotiations with President Obama and his top aides throughout the spring of 2009, Big Pharma offered its support for comprehensive health care reform and pledged to cut $80 billion in costs over the next ten years. Just exactly what Obama promised in return wasn’t made public and was the subject of intense debate on Capitol Hill, as senators wondered aloud if the White House had tied their legislative hands.
There were reports that Obama had promised to oppose any congressional attempt to exact further money from the massive pharmaceutical industry, which would include allowing Medicare to negotiate for lower prices or import cheaper drugs from Canada — two major priorities for congressional Democrats. In other words, scratch my back and I’ll do all that I can to get Congress off your back and thus leave your billion dollar drug industry alone.
Realize, pediatric psychopharmacology is a billion-dollar business that sustains Big Pharma, Pharma investors on Wall Street, doctors, researchers, medical centers, clinical research organizations, medical journals, Big Pharma’s PR and ghostwriting firms, pharmacy benefits managers, and the FDA itself—which judges its value on how many drugs it approves. The only losers are kids given a probable life sentence of expensive and dangerous drugs, the families of these children, and the taxpayers and insured persons who pay for the drugs.
The father of pediatric psychopharmacology, Harvard child psychiatrist Joseph Biederman, is often called Joseph “Risperdal” Biederman, because he is credited with ballooning the diagnosis of bipolar disorder in children by as much as fortyfold. In 2008, Biederman, a prolific author who has written five hundred scientific articles and seventy book chapters, was investigated by Congress for allegedly accepting Pharma money he didn’t disclose, and he agreed to suspend his industry-related activities. After a three-year investigation, Harvard “threw the book” at Biederman and two other professors: they were required to “refrain from all paid industry-sponsored outside activities for one year and comply with a two-year monitoring period afterward, during which they must obtain approval from the Medical School and Massachusetts General Hospital before engaging in any paid activities.”